Leo Cancer Care Secures CE Mark for Marie®, Advancing Upright Radiotherapy in Europe
May 20, 2026
Leo Cancer Care’s CE mark approval for Marie® signals a transformative shift in how radiotherapy is delivered across Europe.
Leo Cancer Care’s CE mark approval for Marie® signals a transformative shift in how radiotherapy is delivered across Europe.
Asthma-related pathway helps tumors evade immune attack in triple-negative breast cancer, other tough cancers
The lightweight, at-home sensor records MJM, a validated biosignal for sleep evaluation.
According to Guardant, Guardant360 Liquid assesses a ‘100x wider’ genomic footprint to guide cancer treatment decisioning than its predecessor.
Sentante announced today that it received CE mark for its flagship endovascular surgical robot platform for treating stroke.